TAG:
lab test
LabCorp’s Smith Speaks On New Pathology Trend
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
CEO SUMMARY: During the past decade, Laboratory Corporation of America’s Brad Smith faced the spear point of evolving Medicare/Medicaid compliance initiatives which changed so many laboratory industry business practices. Smith believes that business models for in-house anatomic patholog…
Two Blockbuster Stories to Rock the Lab Industry!
By R. Lewis Dark | From the Volume XI No. 10 – July 19, 2004 Issue
WOW! YOU HAVE TWO BLOCKBUSTER STORIES covered in this issue, which expanded into extra pages to bring you all the news and detailed analysis. Our lead story, on the facing page, is first news in the laboratory industry of criminal indictments of three ex-UroCor executives for laborat…
UroCor’s Sales Tactics Violated Medicare Laws
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: By issuing a multi-count criminal indictment against three former UroCor executives, one federal attorney is creating new legal precedents for the laboratory industry. The criminal charges accuse UroCor of inducing physicians through such gambits as deeply-discounted pricing …
Lawyer Argues: UroCor Charges Are a Concern
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Criminal charges in the case against three ex-UroCor executives will likely alter existing compliance practices that affect how a lab offers price discounts to physicians and the way a lab uses “waiver of charges” in situations where it is an out-of-network provider. Atto…
Linking UroCor Indictments With Specialist Doc Pathology
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
IS THE TIMING of the criminal indictments of three ex-UroCor executives going to be a fortuitous event for the anatomic pathology profession? I ask this question because the exploding trend of specialist physician groups internalizing anatomic pathology services was slated to be the…
Pathology “Condo Labs” Are New Business Ploy
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: We call ‘em pathology condominium laboratories. Other names are “pod labs” and “salon labs.” Whatever name is used, this new scheme by specialist physicians to capture pathology revenues may be the most significant threat to the anatomic pathology profession since t…
“July 19, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
A transfusion of the wrong type of blood may have contributed to the death of a critically ill woman at Sarasota Memorial Hospital in Sarasota, Florida last month. The patient died about a day after the transfusion. Following the blood transfusion, a reaction had been observed. Atten…
Esoterix & UnitedHealth Sign National Test Pact
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
CEO SUMMARY: Just when it is assumed that the two blood brothers have a lock on national lab testing contracts with the nation’s biggest payers, Esoterix inks an agreement with UnitedHealth Group. This now positions Esoterix to offer its higher-end reference and esoteric testing to hosp…
UnitedHealth’s Decision Reveals Lab Market Shift
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
CEO SUMMARY: News that UnitedHealth Group, Inc. added Esoterix, Inc. to its national laboratory services contract is a big story. UnitedHealth’s decision to expand the laboratory panel demonstrates that factors other than lowest price played an important role. The move to supplement its…
National AP Firms Target Gastroenterology Groups
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
CEO SUMMARY: It’s a trend as yet invisible to the radar screens of most pathology groups. A new crop of specialty AP companies is targeting gastroenterology. In the past 36 months, several have posted phenomenal growth in both specimen volume and revenue. The heightened competition for …
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized